Delcath Systems, INC. (DCTH) — SEC Filings

Overview

Delcath Systems, INC. (DCTH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a ARS filed on Apr 2, 2026: Delcath Systems, Inc. filed its Annual Report to Security Holders (ARS) on April 2, 2026, for the period ending December 31, 2025. The filing includes the company's 10-K report, which details its financial performance and business operations for the fiscal year 2025. The company is involved in the S

Sentiment Summary

Across 42 filings, the sentiment breakdown is: 2 bullish, 4 bearish, 36 neutral. The dominant filing sentiment for Delcath Systems, INC. is neutral.

Filing Type Overview

Delcath Systems, INC. (DCTH) has filed 1 ARS, 1 DEFA14A, 20 8-K, 6 10-Q, 2 DEF 14A, 1 10-K, 3 SC 13D/A, 7 SC 13G/A, 1 SC 13G with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (42)

• Delcath Systems Files 2025 Annual Report — ARS · Apr 2, 2026 Risk: low
  Delcath Systems, Inc. filed its Annual Report to Security Holders (ARS) on April 2, 2026, for the period ending December 31, 2025. The filing includes the compa
• DEFA14A Filing — DEFA14A · Apr 2, 2026
• Delcath Systems Files 8-K Report — 8-K · Nov 20, 2025 Risk: medium
  On November 19, 2025, Delcath Systems, Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events." No specifi
• Delcath's Revenue Soars 192% YTD on HEPZATO Traction, CHOPIN Trial Boosts Outlook — 10-Q · Nov 4, 2025 Risk: medium
  DELCATH SYSTEMS, INC. (DCTH) reported a significant increase in product revenue, reaching $20.563 million for the three months ended September 30, 2025, up from
• Delcath Systems Files 8-K on Operations and Financials — 8-K · Oct 20, 2025 Risk: low
  Delcath Systems, Inc. filed an 8-K on October 20, 2025, reporting on events that occurred on October 18, 2025. The filing pertains to results of operations, fin
• Delcath Systems Changes Fiscal Year End — 8-K · Aug 15, 2025 Risk: low
  Delcath Systems, Inc. filed an 8-K on August 15, 2025, reporting a change in its fiscal year end to December 31st. This filing also includes financial statement
• Delcath's Q2 Loss Widens to $10.2M Amid Capital Structure Shifts — 10-Q · Aug 6, 2025 Risk: high
  DELCATH SYSTEMS, INC. reported a net loss of $10.2 million for the three months ended June 30, 2025, compared to a net loss of $9.5 million for the same period
• Delcath Systems Files 8-K Report — 8-K · May 22, 2025 Risk: low
  On May 22, 2025, Delcath Systems, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regul
• Delcath Systems Files 8-K: Director/Officer Changes & Shareholder Votes — 8-K · May 16, 2025 Risk: medium
  Delcath Systems, Inc. filed an 8-K on May 16, 2025, reporting on events as of May 15, 2025. The filing covers the departure of directors or certain officers, th
• Delcath Systems Files 10-Q for Q1 2025 — 10-Q · May 8, 2025 Risk: medium
  Delcath Systems, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations. Specific financial
• Delcath Systems Files 2025 Proxy Statement — DEF 14A · Apr 1, 2025 Risk: low
  Delcath Systems, Inc. filed its DEF 14A on April 1, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corp
• Delcath Systems Appoints New Auditor — 8-K · Mar 21, 2025 Risk: low
  Delcath Systems, Inc. announced on March 18, 2025, that it has appointed a new independent registered public accounting firm, WithumSmith+Brown, PC. This change
• Delcath Systems Files 2024 10-K — 10-K · Mar 6, 2025 Risk: medium
  Delcath Systems, Inc. filed its 2024 10-K on March 6, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, incor
• DELCATH SYSTEMS, INC. Files Current Report — 8-K · Jan 13, 2025 Risk: low
  On January 13, 2025, DELCATH SYSTEMS, INC. filed an 8-K report. The filing indicates the company's principal executive offices are located at 566 Queensbury Ave
• Delcath Systems Files 8-K: Key Updates — 8-K · Dec 30, 2024 Risk: medium
  Delcath Systems, Inc. filed an 8-K on December 30, 2024, reporting events that occurred on December 23, 2024. The filing includes information related to Regulat
• Rosalind Advisors Files 13D/A for Delcath Systems — SC 13D/A · Nov 14, 2024 Risk: medium
  Rosalind Advisors, Inc. and its affiliates, including Steven A. J. Salamon, have filed an amendment to their Schedule 13D, reporting their beneficial ownership
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Delcath Systems Files Q3 2024 10-Q — 10-Q · Nov 8, 2024 Risk: medium
  Delcath Systems, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its business o
• SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• Delcath Systems Files 8-K: Financial and Operational Updates — 8-K · Oct 17, 2024 Risk: medium
  On October 17, 2024, Delcath Systems, Inc. filed an 8-K report detailing significant financial and operational updates. The filing indicates a shift in the comp
• Delcath Systems Files 8-K: Regulation FD Disclosure — 8-K · Aug 29, 2024 Risk: low
  Delcath Systems, Inc. filed an 8-K on August 29, 2024, reporting an event on August 28, 2024. The filing is a Regulation FD Disclosure and includes Financial St
• Delcath Systems Files 8-K Report — 8-K · Aug 28, 2024 Risk: low
  On August 26, 2024, Delcath Systems, Inc. filed an 8-K report detailing other events and financial statements. The company, incorporated in Delaware with its pr
• Delcath Systems Files Q2 2024 10-Q — 10-Q · Aug 5, 2024 Risk: medium
  Delcath Systems, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarte
• Delcath Systems Appoints New CFO — 8-K · Jul 19, 2024 Risk: low
  On July 16, 2024, Delcath Systems, Inc. announced the appointment of Kevin T. O'Malley as its new Chief Financial Officer. O'Malley, who previously served as CF
• Delcath Systems Faces Nasdaq Delisting Warning — 8-K · Jul 9, 2024 Risk: high
  Delcath Systems, Inc. announced on July 8, 2024, that it received a notification from Nasdaq regarding its failure to meet the minimum bid price requirement for
• Delcath Systems Faces Nasdaq Delisting Notice — 8-K · May 29, 2024 Risk: high
  Delcath Systems, Inc. announced on May 23, 2024, that it received a notice from Nasdaq indicating it is not in compliance with listing rules. The company has 18
• Rosalind Advisors Amends Delcath Systems Stake — SC 13D/A · May 17, 2024 Risk: medium
  Rosalind Advisors, Inc. and its affiliates have filed an amendment (No. 10) to their Schedule 13D concerning Delcath Systems, Inc. The filing, dated May 17, 202
• DELCATH SYSTEMS, INC. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024 Risk: low
  DELCATH SYSTEMS, INC. (DCTH) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. DELCATH SYSTEMS, INC. filed a 10-Q report for the period ending March
• Delcath Systems, Inc. Files Material Definitive Agreement — 8-K · Apr 26, 2024 Risk: medium
  On April 22, 2024, Delcath Systems, Inc. entered into a Material Definitive Agreement. The filing does not specify the nature of the agreement or any associated
• Delcath Systems, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 12, 2024 Risk:
  DELCATH SYSTEMS, INC. (DCTH) filed a Proxy Statement (DEF 14A) with the SEC on April 12, 2024. The 2024 Annual Meeting of Stockholders for Delcath Systems, Inc.
• DELCATH SYSTEMS, INC. Files 8-K on Financials — 8-K · Mar 26, 2024 Risk: low
  On March 26, 2024, DELCATH SYSTEMS, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well
• Rosalind Advisors Amends Delcath Systems Stake — SC 13D/A · Mar 25, 2024 Risk: medium
  Rosalind Advisors, Inc. and its affiliates, including Rosalind Master Fund L.P. and Rosalind Opportunities Fund I L.P., have filed an amendment (No. 10) to thei
• Delcath Systems Announces Board and Officer Changes — 8-K · Mar 19, 2024 Risk: medium
  On March 18, 2024, Delcath Systems, Inc. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes the electio
• Delcath Systems Reports Executive & Director Changes — 8-K · Feb 14, 2024 Risk: medium
  DELCATH SYSTEMS, INC. filed an 8-K on February 14, 2024, reporting events that occurred on February 9, 2024. The filing indicates changes related to the departu
• SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Vivo Opportunity Fund Holdings Updates Delcath Systems Stake — SC 13G/A · Feb 13, 2024 Risk: low
  Vivo Opportunity Fund Holdings, L.P. filed an amended Schedule 13G/A on February 13, 2024, disclosing its beneficial ownership in Delcath Systems, Inc. As of De
• Stonepine Capital Exits Significant Delcath Systems Stake — SC 13G/A · Feb 13, 2024 Risk: medium
  Stonepine Capital Management, LLC filed an amended SC 13G/A on February 13, 2024, indicating a change in their beneficial ownership of Delcath Systems, Inc. (DC
• Soleus Capital Amends 13G for Delcath Systems, Inc. Stake — SC 13G/A · Feb 2, 2024
  Soleus Capital Master Fund, L.P. filed an amendment to its Schedule 13G on February 2, 2024, indicating its ownership of Delcath Systems, Inc. common stock as o
• DELCATH SYSTEMS Files Routine 8-K, Confirms NASDAQ Listing — 8-K · Jan 31, 2024
  DELCATH SYSTEMS, INC. (DCTH) filed an 8-K on January 31, 2024, to update its registration information with the SEC. This filing primarily confirms the company's
• AIGH Capital Takes 5.0% Stake in Delcath Systems — SC 13G · Jan 9, 2024
  AIGH Capital Management, LLC, a Maryland-based entity, reported acquiring 1,539,638 shares of Delcath Systems, Inc. common stock, representing a 5.0% ownership
• DELCATH SYSTEMS Files 8-K for Jan 5 Event; Routine Disclosure — 8-K · Jan 8, 2024
  DELCATH SYSTEMS, INC. (DCTH) filed an 8-K on January 8, 2024, reporting an event that occurred on January 5, 2024. This filing is a routine disclosure under Reg

Risk Profile

Risk Assessment: Of DCTH's 32 recent filings, 3 were flagged as high-risk, 16 as medium-risk, and 13 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Delcath Systems, INC.'s most recent 10-Q filing (Nov 4, 2025):

• Revenue: $64.503M
• Net Income: $4.596M
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: $41.813M
• Operating Margin: N/A
• Total Assets: N/A
• Total Debt: N/A

Key Executives

• melphalan
• ipilimumab
• nivolumab
• Steven A. J. Salamon
• Kevin T. O'Malley
• Steven A. Salamon
• Aharon Gil

Industry Context

Delcath Systems operates in the oncology therapeutics market, focusing on novel drug-device combination therapies. The industry is characterized by high R&D costs, long development cycles, and intense competition from both large pharmaceutical companies and smaller biotech firms. There is a growing trend towards personalized medicine and combination therapies to improve patient outcomes, which aligns with Delcath's strategic focus.

Top Tags

financials (8) · 8-K (7) · disclosure (5) · sec-filing (4) · 10-Q (4) · compliance (4) · institutional-ownership (4) · corporate-governance (3) · ownership-change (3) · schedule-13d (3)

Key Numbers

• Product revenue for nine months ended Sept 30, 2025: $64.503M — Increased 192% from $22.105M in 2024
• Net income for nine months ended Sept 30, 2025: $4.596M — Improved from a net loss of $22.988M in 2024
• One-year progression-free survival rate in CHOPIN combination group: 54.7% — Compared to 15.8% in the PHP group
• Cash and cash equivalents as of Sept 30, 2025: $41.813M — Increased from $32.412M at Dec 31, 2024
• Shares of common stock outstanding as of Oct 27, 2025: 35,313,718 — Reflects recent equity activity
• Product revenue increase for three months ended Sept 30, 2025: 83.6% — From $11.200M in 2024 to $20.563M in 2025
• Total stockholders' equity as of Sept 30, 2025: $114.847M — Increased from $68.746M at Dec 31, 2024
• Median Overall Survival (OS) in CHOPIN combination group: 23.1 months — Versus 19.6 months in the PHP group (HR = 0.39; p = 0.006)
• Overall Response Rate (ORR) in CHOPIN combination group: 76.3% — Versus 39.5% in the PHP group (p<0.001)
• Net cash provided by operating activities for nine months ended Sept 30, 2025: $14.268M — Improved from net cash used of $17.675M in 2024
• Fiscal Year End: 1231 — The company has changed its fiscal year end to December 31st.
• Net Loss: $10.2M — Increased from $9.5M in Q2 2024 to $10.2M in Q2 2025, indicating widening losses.
• Increase in Net Loss: 7.4% — Percentage increase in net loss from Q2 2024 to Q2 2025.
• Period End Date: 2025-06-30 — The end date for the reported financial quarter.
• Central Index Key (CIK): 0000872912 — Unique identifier for DELCATH SYSTEMS, INC. with the SEC.

Forward-Looking Statements

• {"claim":"Vivo Opportunity Fund Holdings, L.P. will maintain a significant stake in Delcath Systems, Inc.","entity":"Vivo Opportunity Fund Holdings, L.P.","targetDate":"Q2 2024","confidence":"medium"}
• {"claim":"Delcath Systems, Inc. stock may experience increased volatility due to the reduction in institutional ownership.","entity":"Delcath Systems, Inc.","targetDate":"Q2 2024","confidence":"medium"}

Related Companies

DELC

Frequently Asked Questions